Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ribonucleotides | 1 | 2024 | 36 | 0.890 |
Why?
|
| RNA Stability | 1 | 2024 | 84 | 0.870 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2024 | 217 | 0.860 |
Why?
|
| Child, Hospitalized | 1 | 2023 | 76 | 0.770 |
Why?
|
| Urinary Tract Infections | 2 | 2023 | 244 | 0.730 |
Why?
|
| Aneuploidy | 2 | 2019 | 145 | 0.600 |
Why?
|
| Probiotics | 1 | 2021 | 229 | 0.590 |
Why?
|
| Telomerase | 2 | 2015 | 179 | 0.540 |
Why?
|
| Acute Kidney Injury | 1 | 2023 | 696 | 0.470 |
Why?
|
| Breast Neoplasms | 2 | 2024 | 2763 | 0.440 |
Why?
|
| Telomere | 1 | 2015 | 230 | 0.420 |
Why?
|
| Cell Line, Tumor | 5 | 2024 | 3751 | 0.220 |
Why?
|
| Lipid Peroxidation | 2 | 2024 | 99 | 0.220 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2023 | 82 | 0.200 |
Why?
|
| Income | 1 | 2023 | 140 | 0.190 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2021 | 267 | 0.170 |
Why?
|
| Spliceosomes | 1 | 2021 | 57 | 0.170 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2020 | 19 | 0.170 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2021 | 128 | 0.160 |
Why?
|
| Immunity | 1 | 2021 | 188 | 0.160 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2019 | 32 | 0.160 |
Why?
|
| Mice | 7 | 2024 | 18909 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2024 | 2122 | 0.150 |
Why?
|
| Reperfusion Injury | 1 | 2020 | 124 | 0.150 |
Why?
|
| Nephrosis | 1 | 2018 | 6 | 0.150 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 395 | 0.150 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 177 | 0.150 |
Why?
|
| Hernia, Hiatal | 1 | 2018 | 60 | 0.150 |
Why?
|
| Lymphoma, B-Cell | 1 | 2019 | 150 | 0.140 |
Why?
|
| GTP-Binding Proteins | 1 | 2018 | 188 | 0.140 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 609 | 0.130 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 1206 | 0.130 |
Why?
|
| Animals | 7 | 2024 | 36387 | 0.120 |
Why?
|
| Microcephaly | 1 | 2018 | 347 | 0.120 |
Why?
|
| Kidney | 2 | 2020 | 1417 | 0.120 |
Why?
|
| Incidence | 1 | 2023 | 3402 | 0.120 |
Why?
|
| RNA Polymerase I | 1 | 2014 | 11 | 0.110 |
Why?
|
| Humans | 12 | 2024 | 133935 | 0.110 |
Why?
|
| DNA, Ribosomal | 1 | 2014 | 56 | 0.110 |
Why?
|
| Child | 4 | 2023 | 25742 | 0.110 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 3740 | 0.110 |
Why?
|
| Cellular Senescence | 1 | 2015 | 201 | 0.100 |
Why?
|
| DNA Replication | 1 | 2015 | 363 | 0.100 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2024 | 67 | 0.090 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2015 | 563 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 792 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 2519 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 1757 | 0.080 |
Why?
|
| Neoplasms | 1 | 2024 | 3027 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2014 | 2539 | 0.070 |
Why?
|
| Fibroblasts | 2 | 2020 | 922 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 2526 | 0.060 |
Why?
|
| Mutation | 1 | 2018 | 6297 | 0.060 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2024 | 5 | 0.050 |
Why?
|
| Succimer | 1 | 2023 | 1 | 0.050 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2024 | 62 | 0.050 |
Why?
|
| Fluorouracil | 1 | 2024 | 141 | 0.050 |
Why?
|
| Urinalysis | 1 | 2023 | 56 | 0.050 |
Why?
|
| Lipid Droplets | 1 | 2024 | 48 | 0.050 |
Why?
|
| Microscopy | 1 | 2023 | 123 | 0.050 |
Why?
|
| Female | 3 | 2024 | 71684 | 0.050 |
Why?
|
| Genes, myc | 1 | 2021 | 107 | 0.040 |
Why?
|
| Triglycerides | 1 | 2024 | 613 | 0.040 |
Why?
|
| RNA, Double-Stranded | 1 | 2021 | 66 | 0.040 |
Why?
|
| Cell Death | 1 | 2021 | 251 | 0.040 |
Why?
|
| Adenosine | 1 | 2021 | 139 | 0.040 |
Why?
|
| Cyclohexylamines | 1 | 2020 | 6 | 0.040 |
Why?
|
| Gene Amplification | 1 | 2021 | 247 | 0.040 |
Why?
|
| A549 Cells | 1 | 2020 | 49 | 0.040 |
Why?
|
| Adult | 1 | 2021 | 31950 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 97 | 0.040 |
Why?
|
| Phenylenediamines | 1 | 2020 | 30 | 0.040 |
Why?
|
| Introns | 1 | 2021 | 313 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2021 | 302 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2021 | 248 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 110 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2021 | 777 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2020 | 232 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2021 | 250 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2021 | 676 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 407 | 0.040 |
Why?
|
| Piperazines | 1 | 2020 | 257 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 1006 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2020 | 271 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2020 | 464 | 0.040 |
Why?
|
| Genes, Recessive | 1 | 2018 | 194 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2021 | 4899 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2020 | 328 | 0.030 |
Why?
|
| Iron | 1 | 2020 | 303 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2020 | 417 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2019 | 644 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2020 | 1701 | 0.030 |
Why?
|
| Glucose | 1 | 2020 | 924 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2020 | 812 | 0.030 |
Why?
|
| Liver Regeneration | 1 | 2014 | 40 | 0.030 |
Why?
|
| Myofibroblasts | 1 | 2014 | 79 | 0.030 |
Why?
|
| Apoptosis | 1 | 2021 | 1930 | 0.030 |
Why?
|
| Rabbits | 1 | 2014 | 736 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 2656 | 0.020 |
Why?
|
| Protein Binding | 1 | 2014 | 1832 | 0.020 |
Why?
|
| Cell Line | 1 | 2014 | 2836 | 0.020 |
Why?
|
| Infant | 1 | 2023 | 13163 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 648 | 0.020 |
Why?
|
| Liver | 1 | 2014 | 1875 | 0.020 |
Why?
|
| Lung | 1 | 2014 | 1557 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 4822 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 14802 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 20536 | 0.010 |
Why?
|
| Male | 1 | 2014 | 65904 | 0.000 |
Why?
|